CD4 and Miyoshi myopathy: Lenalidomide was shown to reduce PD-1 expression in all effector cells (CD4+ T cells, CD8+ T cells, NK cells, and NKT cells), and PD-L1 expression in MM cells, MDSC, and monocyte/macrophages in an in vitro experiment (35).